Market Overview:
The global POC diagnostics market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for point-of-care diagnostics from clinics, hospitals, and laboratories across the globe. In addition, technological advancements in POC diagnostics are also contributing to the growth of this market. Based on type, the global POC diagnostics market is segmented into blood glucose testing, infectious diseases testing, cardiac markers testing, coagulation testing, pregnancy and fertility testing, blood gas/electrolytes testing tumor markerstesting urinalysistesting cholesteroltesting among others. Blood glucose Testing held a dominant share in 2017 and is expected to maintain its dominance during the forecast period as well owing to rising prevalence of diabetes mellitus globally. Infectious Diseases Testingis projectedto bethe fastest growing segmentduringthe forecastperioddue tobusinessgrowth opportunitiesin emerging markets such as Asia Pacificand Latin America .
Product Definition:
POC diagnostics is a laboratory technique that is used to detect the presence of a particular substance in a sample. It is important because it allows for the rapid diagnosis of diseases or conditions.
Blood Glucose Testing:
Blood glucose testing is a method used to measure the level of sugar in the blood. Blood glucose tests are commonly used by people with diabetes mellitus for regular monitoring and analysis of blood sugar levels. The tests are also being increasingly adopted by patients suffering from other medical conditions such as obesity, prediabetes, and metabolic syndrome coupled with healthy individuals who desire to maintain optimal health.
Infectious Diseases Testing:
Infectious diseases testing is the process of detection and classification of infectious agents. These tests are used in POC (point-of-care) diagnostics to provide rapid results for clinical decisions.
The global infectious diseases testing market is expected to witness lucrative growth over the forecast period owing to increasing prevalence rate of chronic disorders due to infections, rising demand for home healthcare services, growing geriatric population base, and technological advancements in point-of-care diagnostic devices.
Application Insights:
The clinics segment dominated the global POC diagnostics market in 2017. This is attributed to factors such as increasing awareness about early diagnosis and rising disposable income among the population. For instance, according to a study published by WHO in 2018, around 50% of adults have at least one chronic disease and 30% of these are undiagnosed. Thus, increasing number of patients visiting healthcare providers for various symptoms demand that they be subjected to point-of-care testing for accurate diagnosis.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced diagnostic technologies and increasing healthcare expenditure in this region. Moreover, favorable reimbursement policies are also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness regarding POC diagnostics testing procedures at outpatient clinics and hospitals.
Moreover, a rise in diabetes cases due to changing lifestyles will also contribute towards market growth over time as most of these patients prefer outpatient settings for diagnosis rather than hospital-based laboratories or clinicians’ offices (1). The Latin American region comprises developing economies such as Brazil that have witnessed significant economic development along with improvements in public health systems (2).
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and hypertension is expected to drive the demand for point-of-care diagnostics over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth owing to increase in prevalence of age-related disorders.
- Technological advancements in POC diagnostics are projected to provide lucrative opportunities for market expansion.
- Growing demand for rapid and accurate diagnostic tests is likely to propel the POC diagnostics market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
POC Diagnostics Market Research Report
By Type
Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing
By Application
Clinics, Hospitals, Laboratory, Others
By Companies
Abbott, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global POC Diagnostics Market Report Segments:
The global POC Diagnostics market is segmented on the basis of:
Types
Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Bayer Healthcare
- Beckman Coulter
- Nipro Diagnostics
- Bio-Rad Laboratories
- Nova Biomedical
- BioMerieux
- Quidel
- Helena Laboratories
- OraSure Technologies
- Accriva
- Abaxis
- Chembio Diagnostics
- Trinity Biotech
Highlights of The POC Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Tumor Markers Testing
- Urinalysis Testing
- Cholesterol Testing
- By Application:
- Clinics
- Hospitals
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the POC Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
POC Diagnostics is a diagnostic company that specializes in providing testing and services for people of color. They offer a variety of tests, including screenings for cancer, heart disease, and other diseases. POC Diagnostics also provides educational resources to help people understand their health risks and how to best protect themselves.
Some of the key players operating in the poc diagnostics market are Abbott, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech.
The poc diagnostics market is expected to register a CAGR of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. POC Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. POC Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. POC Diagnostics Market - Supply Chain
4.5. Global POC Diagnostics Market Forecast
4.5.1. POC Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. POC Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. POC Diagnostics Market Absolute $ Opportunity
5. Global POC Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. POC Diagnostics Market Size and Volume Forecast by Type
5.3.1. Blood Glucose Testing
5.3.2. Infectious Diseases Testing
5.3.3. Cardiac Markers Testing
5.3.4. Coagulation Testing
5.3.5. Pregnancy and Fertility Testing
5.3.6. Blood Gas/Electrolytes Testing
5.3.7. Tumor Markers Testing
5.3.8. Urinalysis Testing
5.3.9. Cholesterol Testing
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global POC Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. POC Diagnostics Market Size and Volume Forecast by Application
6.3.1. Clinics
6.3.2. Hospitals
6.3.3. Laboratory
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global POC Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. POC Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global POC Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. POC Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global POC Diagnostics Demand Share Forecast, 2019-2026
9. North America POC Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America POC Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America POC Diagnostics Market Size and Volume Forecast by Application
9.4.1. Clinics
9.4.2. Hospitals
9.4.3. Laboratory
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America POC Diagnostics Market Size and Volume Forecast by Type
9.7.1. Blood Glucose Testing
9.7.2. Infectious Diseases Testing
9.7.3. Cardiac Markers Testing
9.7.4. Coagulation Testing
9.7.5. Pregnancy and Fertility Testing
9.7.6. Blood Gas/Electrolytes Testing
9.7.7. Tumor Markers Testing
9.7.8. Urinalysis Testing
9.7.9. Cholesterol Testing
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America POC Diagnostics Demand Share Forecast, 2019-2026
10. Latin America POC Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America POC Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America POC Diagnostics Market Size and Volume Forecast by Application
10.4.1. Clinics
10.4.2. Hospitals
10.4.3. Laboratory
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America POC Diagnostics Market Size and Volume Forecast by Type
10.7.1. Blood Glucose Testing
10.7.2. Infectious Diseases Testing
10.7.3. Cardiac Markers Testing
10.7.4. Coagulation Testing
10.7.5. Pregnancy and Fertility Testing
10.7.6. Blood Gas/Electrolytes Testing
10.7.7. Tumor Markers Testing
10.7.8. Urinalysis Testing
10.7.9. Cholesterol Testing
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America POC Diagnostics Demand Share Forecast, 2019-2026
11. Europe POC Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe POC Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe POC Diagnostics Market Size and Volume Forecast by Application
11.4.1. Clinics
11.4.2. Hospitals
11.4.3. Laboratory
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe POC Diagnostics Market Size and Volume Forecast by Type
11.7.1. Blood Glucose Testing
11.7.2. Infectious Diseases Testing
11.7.3. Cardiac Markers Testing
11.7.4. Coagulation Testing
11.7.5. Pregnancy and Fertility Testing
11.7.6. Blood Gas/lectrolytes Testing
11.7.7. Tumor Markers Testing
11.7.8. Urinalysis Testing
11.7.9. Cholesterol Testing
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe POC Diagnostics Demand Share, 2019-2026
12. Asia Pacific POC Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific POC Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific POC Diagnostics Market Size and Volume Forecast by Application
12.4.1. Clinics
12.4.2. Hospitals
12.4.3. Laboratory
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific POC Diagnostics Market Size and Volume Forecast by Type
12.7.1. Blood Glucose Testing
12.7.2. Infectious Diseases Testing
12.7.3. Cardiac Markers Testing
12.7.4. Coagulation Testing
12.7.5. Pregnancy and Fertility Testing
12.7.6. Blood Gas/Electrolytes Testing
12.7.7. Tumor Markers Testing
12.7.8. Urinalysis Testing
12.7.9. Cholesterol Testing
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific POC Diagnostics Demand Share, 2019-2026
13. Middle East & Africa POC Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa POC Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa POC Diagnostics Market Size and Volume Forecast by Application
13.4.1. Clinics
13.4.2. Hospitals
13.4.3. Laboratory
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa POC Diagnostics Market Size and Volume Forecast by Type
13.7.1. Blood Glucose Testing
13.7.2. Infectious Diseases Testing
13.7.3. Cardiac Markers Testing
13.7.4. Coagulation Testing
13.7.5. Pregnancy and Fertility Testing
13.7.6. Blood Gas/Electrolytes Testing
13.7.7. Tumor Markers Testing
13.7.8. Urinalysis Testing
13.7.9. Cholesterol Testing
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa POC Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global POC Diagnostics Market: Market Share Analysis
14.2. POC Diagnostics Distributors and Customers
14.3. POC Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Siemens Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Danaher
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bayer Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Beckman Coulter
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Nipro Diagnostics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bio-Rad Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nova Biomedical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BioMerieux
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Quidel
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Helena Laboratories
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. OraSure Technologies
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Accriva
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Abaxis
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Chembio Diagnostics
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Trinity Biotech
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
